The Safety Profile of Concurrent Therapy for Multiple Myeloma in the Modern Era
2018 · Advances in Radiation Oncology · 16 citations
https://doi.org/10.1016/j.adro.2018.09.009
M
Meng Ru
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
107
Papers
788
Citations
16
h-index
22
i10-index
Meng Ru is an academic researcher from China Animal Disease Control Center. The author has contributed to research in topics: Advanced Breast Cancer Therapies & Breast Cancer Treatment Studies & Cancer Treatment and Pharmacology. The author has an h-index of 16, co-authored 91 publications.
ORCID: 0000-0002-1439-6451Papers by this author
worksUse of neoadjuvant versus adjuvant chemotherapy for hormone receptor-positive breast cancer: a National Cancer Database (NCDB) study
2020 · Breast Cancer Research and Treatment · 16 citations
https://doi.org/10.1007/s10549-020-05809-w
Trends in neoadjuvant chemotherapy versus surgery-first in stage I HER2-positive breast cancer patients in the National Cancer DataBase (NCDB)
2021 · Breast Cancer Research and Treatment · 13 citations
https://doi.org/10.1007/s10549-020-06041-2
Practice Changing Potential of TAILORx: A Retrospective Review of the National Cancer Data Base from 2010 to 2015
2019 · Annals of Surgical Oncology · 9 citations
https://doi.org/10.1245/s10434-019-07650-y
Prognostic Factors and Survival Outcomes among Patients with Breast Cancer and Brain Metastases at Diagnosis: A National Cancer Database Analysis
2021 · Oncology · 9 citations
https://doi.org/10.1159/000512212
The impact of radiation treatment planning technique on unplanned hospital admissions
2018 · Advances in Radiation Oncology · 4 citations
https://doi.org/10.1016/j.adro.2018.06.006
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat